Studies of Femara at lower dosages?

Save as Favorite
Sign in to receive recommendations (Learn more)
Question from Susie: Are there any ongoing studies for Femara at lower doses?
Answers - Ruth Oratz, M.D., F.A.C.P. No. We've done many clinical trials with all of the aromatase inhibitors, and the current doses that are approved and in clinical use have been carefully delineated in large clinical trials.

The Ask-the-Expert Online Conference called Open for Your Questions featured Ruth Oratz, M.D., F.A.C.P. and moderator Beth Baughman DuPree, M.D., F.A.C.S. answering your questions covering a wide variety of issues relating to breast cancer.

Editor's Note: This conference took place in September 2006.

The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.



Eventtoolkit banner 300x125
Back to Top